What Challenges Exist in Nanotechnology-Based Antithrombotic Therapy?
Despite its promise, nanotechnology-based antithrombotic therapy faces several challenges. These include biocompatibility issues, potential toxicity of certain nanoparticles, and the complexity of large-scale manufacturing. Regulatory hurdles also pose significant challenges, as the safety and efficacy of these advanced materials need to be thoroughly validated.
